107 related articles for article (PubMed ID: 18256973)
1. Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy.
Pitocco D; Collina MC; Musella T; Ruotolo V; Caputo S; Manto A; Caradonna P; Galli M; Mancini L; Ghirlanda G
Horm Metab Res; 2008 Mar; 40(3):163-4. PubMed ID: 18256973
[No Abstract] [Full Text] [Related]
2. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial.
Pitocco D; Ruotolo V; Caputo S; Mancini L; Collina CM; Manto A; Caradonna P; Ghirlanda G
Diabetes Care; 2005 May; 28(5):1214-5. PubMed ID: 15855594
[No Abstract] [Full Text] [Related]
3. A review of bone metabolism and developments in medical treatment of the diabetic Charcot foot.
Jansen RB; Svendsen OL
J Diabetes Complications; 2018 Jul; 32(7):708-712. PubMed ID: 29857955
[TBL] [Abstract][Full Text] [Related]
4. Acute neuropathic joint disease: a medical emergency?
Jeffcoate WJ; Game FL; Armstrong DG; Cavanagh PR
Diabetes Care; 2006 Apr; 29(4):951-2; author reply 952. PubMed ID: 16602195
[No Abstract] [Full Text] [Related]
5. A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy.
Al-Nammari SS; Timothy T; Afsie S
Foot Ankle Surg; 2013 Dec; 19(4):212-7. PubMed ID: 24095226
[TBL] [Abstract][Full Text] [Related]
6. Diabetes and acute Charcot neuroarthropathy--a call for heightened vigilance.
Iheonunekwu N; Ibrahim TM; Ojuro I
Niger J Med; 2010; 19(2):239-40. PubMed ID: 20642098
[No Abstract] [Full Text] [Related]
7. Medical treatment of Charcot neuroosteoarthropathy.
Jostel A; Jude EB
Clin Podiatr Med Surg; 2008 Jan; 25(1):63-9, vi-vii. PubMed ID: 18165112
[TBL] [Abstract][Full Text] [Related]
8. Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment.
Molines L; Darmon P; Raccah D
Diabetes Metab; 2010 Sep; 36(4):251-5. PubMed ID: 20570543
[TBL] [Abstract][Full Text] [Related]
9. Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.
Naqvi A; Cuchacovich R; Saketkoo L; Espinoza LR
Am J Med Sci; 2008 Feb; 335(2):145-8. PubMed ID: 18277124
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and medical management of diabetic Charcot neuroarthropathy.
Mascarenhas JV; Jude EB
Med Clin North Am; 2013 Sep; 97(5):857-72. PubMed ID: 23992897
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?
Selby PL; Young MJ; Boulton AJ
Diabet Med; 1994; 11(1):28-31. PubMed ID: 8181248
[TBL] [Abstract][Full Text] [Related]
12. The effects of systemic alendronate with or without intraalveolar collagen sponges on postextractive bone resorption: a single masked randomized clinical trial.
Graziani F; Rosini S; Cei S; La Ferla F; Gabriele M
J Craniofac Surg; 2008 Jul; 19(4):1061-6. PubMed ID: 18650733
[TBL] [Abstract][Full Text] [Related]
13. Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
Das L; Rastogi A; Jude EB; Prakash M; Dutta P; Bhansali A
PLoS One; 2021; 16(11):e0259224. PubMed ID: 34748565
[TBL] [Abstract][Full Text] [Related]
14. [Alendronate and resorptive hypercalciuria].
Arrabal-Polo MA; Arrabal-Martin M; Zuluaga-Gomez A
Med Clin (Barc); 2011 Sep; 137(7):333. PubMed ID: 21543092
[No Abstract] [Full Text] [Related]
15. Role of body mass index in acute charcot neuroarthropathy.
Ross AJ; Mendicino RW; Catanzariti AR
J Foot Ankle Surg; 2013; 52(1):6-8. PubMed ID: 23260985
[TBL] [Abstract][Full Text] [Related]
16. The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial.
Pakarinen TK; Laine HJ; Mäenpää H; Mattila P; Lahtela J
Diabetes Care; 2011 Jul; 34(7):1514-6. PubMed ID: 21593295
[TBL] [Abstract][Full Text] [Related]
17. Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
Zikan V; Stepan JJ
Bone; 2009 Apr; 44(4):634-8. PubMed ID: 19150421
[TBL] [Abstract][Full Text] [Related]
18. Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.
Jeffcoate WJ
Curr Diab Rep; 2005 Dec; 5(6):430-5. PubMed ID: 16316593
[TBL] [Abstract][Full Text] [Related]
19. The diabetic Charcot foot.
Dissanayake SU; Bowling FL; Jude EB
Curr Diabetes Rev; 2012 May; 8(3):191-4. PubMed ID: 22429012
[TBL] [Abstract][Full Text] [Related]
20. Intragastric alendronate therapy in two infants with vitamin D intoxication: a new method.
Doneray H; Ozkan B; Caner I; Ozkan A; Karakelleoglu C
Clin Toxicol (Phila); 2008 Apr; 46(4):300-2. PubMed ID: 18363123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
